152 related articles for article (PubMed ID: 21338604)
1. Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.
Brumlik MJ; Nkhoma S; Kious MJ; Thompson GR; Patterson TF; Siekierka JJ; Anderson TJ; Curiel TJ
Exp Parasitol; 2011 Jun; 128(2):170-5. PubMed ID: 21338604
[TBL] [Abstract][Full Text] [Related]
2. Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection.
Wei S; Daniel BJ; Brumlik MJ; Burow ME; Zou W; Khan IA; Wadsworth S; Siekierka J; Curiel TJ
Antimicrob Agents Chemother; 2007 Dec; 51(12):4324-8. PubMed ID: 17923491
[TBL] [Abstract][Full Text] [Related]
3. Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplasma gondii replication.
Wei S; Marches F; Daniel B; Sonda S; Heidenreich K; Curiel T
Int J Parasitol; 2002 Jul; 32(8):969-77. PubMed ID: 12076626
[TBL] [Abstract][Full Text] [Related]
4. Reversal of chloroquine and mefloquine resistance in Plasmodium falciparum by the two monoindole alkaloids, icajine and isoretuline.
Frédérich M; Hayette MP; Tits M; De Mol P; Angenot L
Planta Med; 2001 Aug; 67(6):523-7. PubMed ID: 11509972
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine potentiates chloroquine and mefloquine effect on multidrug-resistant Plasmodium falciparum in vitro.
Khairul MF; Min TH; Low JH; Nasriyyah CH; A'shikin AN; Norazmi MN; Ravichandran M; Raju SS
Jpn J Infect Dis; 2006 Oct; 59(5):329-31. PubMed ID: 17060702
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes.
Famin O; Ginsburg H
Biochem Pharmacol; 2002 Feb; 63(3):393-8. PubMed ID: 11853690
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo properties of ellagic acid in malaria treatment.
Soh PN; Witkowski B; Olagnier D; Nicolau ML; Garcia-Alvarez MC; Berry A; Benoit-Vical F
Antimicrob Agents Chemother; 2009 Mar; 53(3):1100-6. PubMed ID: 19015354
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium falciparum malaria: rosettes are disrupted by quinine, artemisinin, mefloquine, primaquine, pyrimethamine, chloroquine and proguanil.
Goldring JD; Padayachee T; Ismail I
Mem Inst Oswaldo Cruz; 1999; 94(5):667-74. PubMed ID: 10464415
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibitors of malarial P. Falciparum protein kinase G: Improving the cell activity of a series of imidazopyridines.
Large JM; Birchall K; Bouloc NS; Merritt AT; Smiljanic-Hurley E; Tsagris DJ; Wheldon MC; Ansell KH; Coombs PJ; Kettleborough CA; Whalley D; Stewart LB; Bowyer PW; Baker DA; Osborne SA
Bioorg Med Chem Lett; 2019 Feb; 29(3):509-514. PubMed ID: 30553738
[TBL] [Abstract][Full Text] [Related]
10. Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.
Traoré K; Diakité SAS; Bah S; Konaté DS; Dabitao D; Sanogo I; Sangaré M; Dama S; Keita B; Doumbouya M; Guindo MA; Doumbia S; Diakité M
Drugs R D; 2020 Sep; 20(3):249-255. PubMed ID: 32557086
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum.
Basco LK; Gillotin C; Gimenez F; Farinotti R; Le Bras J
Br J Clin Pharmacol; 1992 May; 33(5):517-20. PubMed ID: 1524966
[TBL] [Abstract][Full Text] [Related]
12. Ligands of the peripheral benzodiazepine receptor are potent inhibitors of Plasmodium falciparum and Toxoplasma gondii in vitro.
Dzierszinski F; Coppin A; Mortuaire M; Dewailly E; Slomianny C; Ameisen JC; DeBels F; Tomavo S
Antimicrob Agents Chemother; 2002 Oct; 46(10):3197-207. PubMed ID: 12234845
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites.
Alcantara LM; Kim J; Moraes CB; Franco CH; Franzoi KD; Lee S; Freitas-Junior LH; Ayong LS
Exp Parasitol; 2013 Jun; 134(2):235-43. PubMed ID: 23541983
[TBL] [Abstract][Full Text] [Related]
14. Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
Wilson DW; Langer C; Goodman CD; McFadden GI; Beeson JG
Antimicrob Agents Chemother; 2013 Mar; 57(3):1455-67. PubMed ID: 23318799
[TBL] [Abstract][Full Text] [Related]
15. The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.
Fivelman QL; Walden JC; Smith PJ; Folb PI; Barnes KI
Trans R Soc Trop Med Hyg; 1999; 93(4):429-32. PubMed ID: 10674097
[TBL] [Abstract][Full Text] [Related]
16. Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay.
Briolant S; Parola P; Fusaï T; Madamet-Torrentino M; Baret E; Mosnier J; Delmont JP; Parzy D; Minodier P; Rogier C; Pradines B
Malar J; 2007 Apr; 6():44. PubMed ID: 17437625
[TBL] [Abstract][Full Text] [Related]
17. Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998.
Schwenke A; Brandts C; Philipps J; Winkler S; Wernsdorfer WH; Kremsner PG
Wien Klin Wochenschr; 2001 Jan; 113(1-2):63-4. PubMed ID: 11233471
[TBL] [Abstract][Full Text] [Related]
18. In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.
Randrianarivelojosia M; Ratsimbasoa A; Randrianasolo L; Randrianarijaona A; Jambou R
East Afr Med J; 2002 May; 79(5):237-41. PubMed ID: 12638806
[TBL] [Abstract][Full Text] [Related]
19. New compounds hybrids 1h-1,2,3-triazole-quinoline against Plasmodium falciparum.
Boechat N; Ferreira Mde L; Pinheiro LC; Jesus AM; Leite MM; Júnior CC; Aguiar AC; de Andrade IM; Krettli AU
Chem Biol Drug Des; 2014 Sep; 84(3):325-32. PubMed ID: 24803084
[TBL] [Abstract][Full Text] [Related]
20. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Meierjohann S; Walter RD; Müller S
Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]